A drug patent gives a company exclusive rights to manufacture a drug for a given period of time (usually 20 years from the application date in the U.S.). When a drug's U.S. patent expires, lower-priced generic versions may be manufactured by other companies using an abbreviated approval process.
U.S. Food and Drug Administration (FDA)
United States Patent and Trademark Office (USPTO)
World Intellectual Property Organization (WIPO)